Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use
US12226405B2 · kind B2 · utility
0Cited by
2References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2021 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | Apr 27, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) or a pharmaceutically acceptable salt form thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to the use of the compounds in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.